Latest News from: UC Davis Comprehensive Cancer Center

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 82
Chen_moon150.jpg

Article ID: 700961

Study seeks to improve cancer survival for Latinos, Asians and Blacks

UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.

Released:
21-Sep-2018 5:05 PM EDT
melnikow.joy.jpg
  • Embargo expired:
    21-Aug-2018 11:00 AM EDT

Article ID: 699049

Research Informs New National Cervical Cancer Screening Recommendation

UC Davis Comprehensive Cancer Center

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

Released:
16-Aug-2018 2:00 PM EDT
Gandara_David_headshot.jpg

Article ID: 698577

Liquid Biopsy Could Ease the Way to Immunotherapy for Lung Cancer

UC Davis Comprehensive Cancer Center

Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden (TMB) accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors. The blood test offers a much less invasive and more repeatable alternative to tissue testing. The study was published online today in Nature Medicine.

Released:
6-Aug-2018 11:05 AM EDT
michaelmoore.jpg

Article ID: 698362

The Surge in Throat Cancer, Especially in Men

UC Davis Comprehensive Cancer Center

Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

Released:
31-Jul-2018 6:05 PM EDT
Rosenberg_Aaron.jpg

Article ID: 696030

Stem Cell Transplants Extend Life for Multiple Myeloma Patients

UC Davis Comprehensive Cancer Center

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

Released:
12-Jun-2018 2:05 PM EDT
Jonas_29.jpg

Article ID: 690825

Acute Myeloid Leukemia Patients Have Reduced Early Mortality at NCI-Designated Cancer Centers

UC Davis Comprehensive Cancer Center

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

Released:
8-Mar-2018 3:30 PM EST

Article ID: 689571

There’s an App for That

UC Davis Comprehensive Cancer Center

UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical student training app.

Released:
14-Feb-2018 4:00 PM EST
Murphy-17.jpg

Article ID: 687453

UC Davis Researcher Urges Caution on Engineered Stem Cells

UC Davis Comprehensive Cancer Center

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.

Released:
3-Jan-2018 5:05 PM EST
Heyer_Wolf_190.jpg

Article ID: 685097

Unlocking the Genetics of Cancer

UC Davis Comprehensive Cancer Center

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.

Released:
28-Nov-2017 3:05 PM EST
melnikow.joy.jpg

Article ID: 680184

The Understudied Consequences of Peripheral Neuropathy after Chemotherapy

UC Davis Comprehensive Cancer Center

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term peripheral neuropathy, leaving little data for patients and clinicians to make informed decisions.

Released:
29-Aug-2017 8:05 AM EDT

Showing results

110 of 82

Chat now!